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Objective: Why some people recover emotionally after diagnosis and treatment of cancer and others do not is poorly understood.  To identify factors around the time of diagnosis that predict longer-term distress is a necessary step in developing interventions to reduce patients’ vulnerability.  This review identified the demographic, clinical, social and psychological factors available at or within 3 months of diagnosis that are reliable predictors of emotional distress at least 12 months later.  Methods: A systematic search of literature for prospective studies addressing our research question and predicting a range of distress outcomes was conducted.  Thirty nine papers (reporting 36 studies) were subjected to narrative synthesis of the evidence.  Results: There was no consistent evidence that demographic, clinical or social factors reliably predicted longer-term distress. Of the psychological factors examined, only baseline distress (significant in 26 out of 30 relevant papers; 24 out of 28 studies) and neuroticism (significant in all five papers/studies that examined it) consistently predicted longer-term distress.  The heterogeneity of included studies, particularly in populations studied and methodology, precluded meta-analytic techniques.  Conclusions: This review supports current clinical guidance advising early assessment of distress as a marker of vulnerability to persistent problems. Additionally, neuroticism is also indicated as a useful marker of vulnerability. However,  the review also highlights that more sophisticated research designs, capable of identifying the psychological processes that underlie the association between these marker variables and persistent distress, are needed before more effective early interventions can be developed.
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1.	Background
Despite improving prognosis, cancer is still a life-threatening disease and diagnosis can have a profound emotional impact.  Around half of all newly diagnosed patients report clinically significant levels of anxiety and /or depression  ADDIN EN.CITE [, ].  For most, distress  resolves without specialist help [], with most of this spontaneous improvement occurring between 4 to 13 months after diagnosis  ADDIN EN.CITE []. However, there are some patients for whom distress does not decline spontaneously or who become distressed at a later stage  ADDIN EN.CITE [, ], with many long-term survivors remaining at risk of clinically significant distress.  Around a third of patients in treatment or long-term follow-up report levels of distress, including anxiety and/or depression, that warrant intervention [].  Annual prevalence of major depression or generalised anxiety disorder remains 22% in the fourth year after breast cancer diagnosis [], while life-time prevalence of cancer-related PTSD is 10-12% for breast cancer and 20% for other cancers [].  Furthermore, a USA population-based survey  ADDIN EN.CITE [] reported 6% prevalence of psychiatric disorders amongst cancer survivors – double that in the non-cancer comparison group – even after controlling for socio-demographic and clinical factors.
It is therefore unsuprising that psychological needs figure prominently among cancer survivors’ concerns [] [].  Unmet psychological needs compromise quality of life of patients and their families.  In addition they increase health care costs because distressed patients make more demands on both primary and secondary care resources  ADDIN EN.CITE [, ].  
Why some people recover emotionally after diagnosis of cancer and others do not is not well understood, even though the last 10-15 years has seen prolific research on psychological morbidity in cancer.  Much of this research has focussed on quantifying prevalence and improving detection of emotional distress rather than identifying causal predictors [].  A smaller body of research has identified factors that are associated with persistent distress and that might therefore be implicated causally in maintaining it.  Cross-sectional studies of this kind, identifying clinical, sociodemographic and psychological correlates of distress are, however, of limited value in identifying potential causal factors.  For this, prospective research is more informative.  We are aware of no existing synthesis of prospective research into predictors of persistent distress following cancer diagnosis.  Therefore, the aim of the present study was to review prospective research that sought to identify variables available at the time of, or measured within three months of, diagnosis) that predict longer-term distress (defined as at least 12 months later). 

2.	Method
Methodology broadly followed the PRISMA Statement [] for conducting and reporting systematic reviews.

2.1 Search strategy and selection criteria
The EBSCO electronic database, which encompasses five medical, nursing and psychology databases (Medline full text, Psychinfo, PsychARTICLES, CINAHL plus, AHMED), was systematically searched from inception to July 2017.  We combined the term ‘cancer’ with terms relating to emotional distress and those commonly used to denote prospective studies (see Table 1 for search strategy in supplementary information).  In addition to generic terms used to denote emotional distress (i.e. anxiety, depression) we included terms commonly used to describe persisting distress in response to a traumatic event such as cancer diagnosis (i.e. post-traumatic stress, adjustment disorder) and one arising specifically in the context of cancer (fear of cancer recurrence). Only English language papers were included.  References of all papers retrieved were searched to ensure that relevant studies had not been missed.

2.2 Inclusion and exclusion criteria
Included studies: (i) used a prospective cohort design; (ii) were published quantitative studies examining predictors (≤3 months after diagnosis) of subsequent emotional distress (≥12 months after diagnosis); (iii) presented results for adult cancer populations with primary non-metastatic cancer separate from any other chronic conditions; (iv) used published and validated outcome measures for emotional distress.  
2.3 Data Extraction
Study screening was shared by three authors (SC, AB and GH) who worked independently and consulted where necessary to resolve ambiguous decisions.  Study titles and, where necessary, abstracts were screened according to the inclusion criteria.  Full text of potentially relevant articles was retrieved and screened.  Data from eligible studies were extracted using a standardised protocol (Appendix 1) and tabulated.  Extracted data included: general study details (author, date, country); participants’ details (age, gender, cancer diagnosis); study design and methodology (sample size and attrition, outcome and predictor variables, timing of baseline and follow-up assessments, analysis method); and a summary of the reported findings (relevant beta coefficients or odds ratios and/or % variance explained).  Data were extracted from each included article independently by one of two authors (SC or GH) with a reliability check for which 10% (selected at random) of papers were also subject to data extraction by the other author.  There were no disagreements.
2.4 Data synthesis
Meta-analytic review was considered inappropriate because the predictor variables and indices of distress varied greatly across the studies.  Therefore a narrative synthesis is provided.
Findings for each distress outcome (anxiety and depression case, anxiety and depression symptoms, trauma symptoms, emotional distress symptoms) are reported within three broad categories of predictor variable: demographic and clinical; social; and psychological. In making inferences about the reliability of prediction by any one variable, we attended particularly to the number of studies in which that variable had been tested and the proportion in which it was significant.

3.	Results
The search yielded 16,702 papers.  After removing duplicates, 4709 papers were then removed by title and a further 1066 by abstract.  The remaining 149 full-text papers were retrieved and read with a final 110 excluded as a result (see Figure 1).  
Thirty nine papers reporting 36 primary studies were included.  Table 2 indicates study sample characteristics; Table 3 (in supplementary information ) summarizes study design and findings, grouped by type of distress.  Table 4 (in supplementary information ) provides a glossary of measures used to assess distress. 
Most studies were conducted in Europe (26 papers, from 23 studies), six in North America (six papers, from six studies) and the remaining seven (seven papers) in Australia, Japan, Hong Kong and Korea.  They predominantly reported breast cancer patients (19 papers from 19 studies), although head and neck, (eight papers from six studies), prostate (five papers from five studies), rectal (two papers from two studies), lung (one paper from one study), gynaecologic (one paper from one study) and heterogeneous cancer populations (five papers from four studies) were also included.  Mean sample ages ranged from 39 to 73 years.  Reflecting the diagnostic groups studied, 18 out of 39 papers (18/36 studies) reported samples that were entirely female. 
Of the 36 primary studies two included a pre-morbid baseline.  For the others, baseline assessments were either before participants received diagnosis (n=2), immediately after diagnosis (n=7), before primary treatment started (n=15) or after primary treatment finished (n=9).  
The predominant indicator of distress was depression (22 papers from 20 studies).  Nine of these papers (from 9 studies) also assessed anxiety.  No paper reported anxiety alone.  Six of these 22 papers (six studies) tested prediction of anxiety and/or depression ‘caseness’ or change in ‘caseness’ at follow-up; the remaining 16 (14 studies) predicted severity, or change in severity, of symptoms.  Emotional distress or functioning was predicted in 13 papers (12 studies), fear of recurrence in two (two studies), and trauma symptoms in eight (eight studies).   
Twenty-seven papers (24 studies) assessed point prevalence of the outcome 12-18 months after baseline, seven (seven studies) at two years, and two (two studies) at five or more years after diagnosis.  In addition, four papers (four studies) assessed predictors of change in depression over the follow-up period.
Most of the papers included multivariate analyses of predictors across more than one category (i.e. demographic and clinical, social, psychological).  Some studies reported sequential analyses to reduce an inital set of potential predictors; in these circumstances, only data from the final analyses were included in this review.  Most papers reported the results of logistic or multiple regression analyses using p <.05 to indicate a significant association, although there was considerable variation in method of entry and ordering of included predictors.

3.1 Socio-demographic and clinical predictors
3.1.1 Age and Gender
Age was a significant predictor in only four of the 27 papers (25 studies) that assessed age effects.  Younger age predicted trauma symptoms [] and emotional distress [] 12 months after breast cancer surgery; it also predicted anxiety and depression, but not trauma symptoms, 12 months after pre-treatment assessment for breast and prostate cancer  ADDIN EN.CITE [], and anxiety 18 months after diagnosis of head and neck cancer  ADDIN EN.CITE [].
In the 16 papers (13 studies) reporting mixed-gender samples, 13 tested the effect of gender but only two (one study) found it a significant predictor.  Female gender predicted emotional distress but not depression 12 months after the start of treatment for head and neck cancer  ADDIN EN.CITE [].  However in a second paper reporting the same study, female gender did predict depression two and three years post-treatment (emotional distress was not reported at these times) [].  
3.1.2 Socio-economic status
Only four other demographic variables (education, income, and social class) were significant predictors in any study.  Twelve papers (twelve studies) tested the effect of education but nine found no effect.  In one clinically heterogeneous cohort, patients with more education (not clearly defined) became less depressed from three to 15 months following diagnosis  ADDIN EN.CITE [].  However, this study only tested clinical and demographic factors, so it is unclear whether educational level would remain significant if social or psychological factors were also included.  In lung cancer patients  ADDIN EN.CITE [], lower educational level predicted depression, but not emotional distress, 12 months after treatment.  In breast cancer patients [] low educational level independently predicted anxiety, but not depression, two years after surgery.
Social class was tested in two papers (two studies) but an effect was found in just one, in which lower class (not clearly defined) predicted anxiety or depression ‘caseness’ 12 months after mastectomy for breast cancer [].  Personal income was tested in just one study [], in which lower income predicted severe trauma symptoms 15 months after surgery for breast cancer. This study again tested demographic variables separately from clinical and other factors.
3.1.3 Clinical, treatment and tumour characteristics
Eight out of ten papers (eight out of ten studies) testing treatment type in breast cancer found no effect either of type of surgery or of type of adjuvant therapy on distress outcomes.  Of the two papers that did report effects, one [] found that undergoing breast-conserving surgery rather than mastectomy or no surgery predicted depression 12 months after diagnosis.  The other [] found no effect of surgery type, but having radiotherapy predicted fewer trauma symptoms at 12 months.  In other cancer populations, just two of ten papers (two out of seven studies) that explored treatment as a predictor of distress outcomes reported an effect.  De Graeff et al  ADDIN EN.CITE [] stated that combination therapy vs single treatment modality predicted emotional distress and depression 12 months post-treatment for head and neck cancer.  However treatment was just one element of a composite variable aggregating tumour site, stage and treatment and, in two further papers reporting the same study  ADDIN EN.CITE [, ], treatment type did not predict depression when considered independently.  A more recent study of a clinically hereogenous population  [] reported that having surgical treatment predicted worse emotional distress over the 12 months since diagnosis, while having radiotherapy predicted worse depression and anxiety.
Of the 12 papers (ten studies) assessing disease-related characteristics (stage, size, site, nodal status) eight (eight studies) found that these did not predict distress.  One paper in a clinically heterogenous sample  ADDIN EN.CITE [] did report that more advanced disease predicted more depression 15 months after diagnosis.  In a study of breast cancer patients [] greater nodal involvement predicted severe symptoms of psychological trauma 15 months after surgery.  Another study  ADDIN EN.CITE [, ] found that cancer stage predicted depression 12 months after treatment for head and neck cancer when entered into the regression model before other pre-treatment variables  ADDIN EN.CITE [].  However, this effect disappeared after controlling for treatment type and recurrence [].  
3.1.4 Physical health 
Half of the 12 papers (five of ten studies) that tested physical health status as a predictor of emotional distress found an effect.  Three studies in breast cancer found that worse pre-diagnosis physical health predicted trauma symptoms [] and worse pre-diagnosis fatigue predicted  depression  ADDIN EN.CITE [, ].  Another study (two papers) found that poorer pre-treatment physical functioning predicted worse depression and emotional distress 12 months after treatment for head and neck cancer  ADDIN EN.CITE [, ].  However a third paper reporting this study found no effect after controlling for treatment type and recurrence [].  Finally, post-operative sleep and health complaints predicted more trauma symptoms (i.e.intrusive thoughts) 18 months after surgery for breast cancer [].  
In summary, with the exception of baseline physical health (which had roughly equal numbers of significant and null findings) there is scarce evidence that baseline demographic or clinical factors predict longer-term distress after cancer diagnosis. 

3.2 Social predictors
Twenty-one of 39 papers (19 studies) explored social factors as potential predictors of distress. 
3.2.1 Relationship status and social network
Ten of eleven papers (eleven studies) exploring the effect of relationship status or living alone found no effect on long term distress. Just one [] reported that, 12 months after mastectomy, married women were more likely than single women to be classified as anxiety or depression cases. 
One paper in head and neck cancer [] examined the influence of social networks and reported that a smaller formal social network  (e.g. doctor, nurse, psychologist) predicted patients who became depressed 12 months after treatment, and a smaller informal social network (i.e. partner, family, friends) predicted those who became depressed at three years. 
3.2.2 Perceived social support 
Four out of 10 papers (three of nine studies) examining social support found it predicted distress.  In one head and neck cancer study, less available support predicted depression one year after treatment after controlling for baseline depression  ADDIN EN.CITE [] while less emotional support predicted depression one to three years after treatment  ADDIN EN.CITE [, ].  In a mixed cancer diagnosis cohort, after controlling for depression, a lack of ‘problem-focussed’ support and more negative interactions with others three months after diagnosis (but not emotional support) predicted depression 12 months later  [].  In one study, in a mixed cancer diagnosis cohort, more supportive social interactions before diagnosis predicted greater emotional distress twelve months after diagnosis [].  
3.2.3 Negative life events
Just three papers (three studies) examined whether distress was predicted by negative life events before cancer  ADDIN EN.CITE [, ] or by previous serious illness  ADDIN EN.CITE [] and all found no effect. 
In summary there is little evidence to suggest baseline social factors are useful predictors of longer-term distress. 

3.3 Psychological predictors 
3.3.1 Emotional distress
Most of the reviewed papers (30 out of 39) examined whether baseline measures of distress predicted distress at follow-up.  In most cases, the same measure of distress was used on both occasions and was the largest or only significant predictor.  Just four papers (four studies) reported that baseline distress did not predict follow-up distress.  In three of these, depression pre-diagnosis [] or at diagnosis  ADDIN EN.CITE [, ] did not predict depression at follow-up (24, 12 and 72 months later, respectively).  The remaining negative finding arose from a study of emotional distress after breast cancer with a follow-up of six years  ADDIN EN.CITE []. 
Four papers (four studies)  ADDIN EN.CITE [, , , ] used different measures of distress at baseline and follow-up.  Three found positive effects.  In one, pre-operative emotional distress predicted anxiety or depression ‘caseness’ 12 months after surgery for breast cancer [].  Another reported that having received treatment for anxiety or depression before diagnosis of breast or gynecological cancer predicted depression 12 months later but not anxiety.  However this variable predicted neither outcome at 18 or 24 month follow-up  ADDIN EN.CITE [].  In the same study, being in treatment for anxiety or depression at the time of diagnosis predicted anxiety 12 and 18 months later and depression at 18 months, but neither outcome at two years  ADDIN EN.CITE [].  The third paper to find an effect of distress assessed at baseline reported that pre-morbid psychiatric history (diagnoses unspecificed) predicted severe trauma 15 months after surgery for breast cancer [].  The final paper [], found that pre-operative diagnosis of Post-Traumatic Stress Disorder did not predict trauma symptoms 12 to 16 months after surgery for breast cancer.
3.3.2 Self-esteem
Only one paper reported data on self-esteem and found no effect of pre-diagnosis self-esteem on 12-month depression in breast cancer patients [].
Coping
Twelve papers (11 studies) examined coping, using a variety of measures to assess cognitive and behavioural strategies.
Five papers (five studies) across breast  ADDIN EN.CITE [, , ], prostate  ADDIN EN.CITE [] and head and neck  ADDIN EN.CITE [] cancer found no effect of coping.  One paper, in head and neck cancer, claimed small benefits of pre-treatment coping through religion 12 months later and small benefits of trying to ameliorate pre-treatment emotional distress three years later [].  However, another paper analysing the same data found no effect of any aspect of coping at 12 months  ADDIN EN.CITE [].  
Coping did predict emotional distress, even after controlling for baseline distress, in the remaining five studies, although findings were diverse.  Pre-treatment ‘fatalism’ predicted depression, but not anxiety, 12-months later in prostate cancer [], whereas fatalism at diagnosis predicted anxiety caseness but not depression caseness 12 months later in breast cancer  ADDIN EN.CITE [].  ‘Helpless/hopeless’ coping predicted depression caseness 12 months after breast cancer diagnosis  ADDIN EN.CITE []. One study reported that specific coping styles predicted cancer patients’ trauma symptom trajectories  in the first year after diagnosis,  ADDIN EN.CITE []. This study identified four different trajectories of trauma symptoms on the basis of latent growth mixture modelling: resilient (low levels of symptoms at each measurement), delayed-recovered (intial low levels of symptoms that increased and then decreased), mild (initial moderate symptoms slowly decreasing over time) and chronic (persistent high levels of trauma symptoms).  Coping by ‘anxious preoccupation’ predicted ‘mild’, ‘chronic’ and ‘delayed-recovered’ symptom trajectories.  Cognitive avoidance predicted a ‘mild’ trajectory. Pre-operative ‘acceptance’ predicted less emotional distress 12 months after surgery for breast cancer [].  Finally, ‘active problem solving’ and ‘positive reframing’ three months after breast cancer diagnosis predicted greater emotional distress six years later  ADDIN EN.CITE [].  
3.3.3 Personality
Thirteen papers (13 studies) examined personality traits, measured around the time of diagnosis.  Five of these (five studies) assessed neuroticism, finding that it predicted distress.  After controlling for baseline distress, it predicted 12-month emotional distress [] in a group with mixed cancer diagnoses, and 12-month emotional distress [], depression []  ADDIN EN.CITE [], anxiety  ADDIN EN.CITE [], and trauma symptoms [] in breast cancer.  In breast and gynecological cancer it also predicted depression at 18 months, and both anxiety and depression 24 months after surgery  ADDIN EN.CITE [].  Finally, in newly diagnosed head and neck cancer patients, controlling for neuroticism reduced to non-significant the correlation between baseline depression and depression at six years (the independent contribution of neuroticism to predicting depression was not reported)  ADDIN EN.CITE []. 
Optimism-pessimism was assessed in five papers (five studies).  In breast cancer  ADDIN EN.CITE [] pessimism at diagnosis predicted anxiety and depression caseness 12 months later after controlling for baseline distress, while post-operative optimism predicted lower levels of anxiety and depression two years after surgery [].  However, three other papers in prostate  ADDIN EN.CITE [] and breast cancer  ADDIN EN.CITE [, ] reported no effect after controlling for baseline distress. 
‘Type C’ personality was assessed in one paper that explored predictors of four different trauma symptom trajectories in the first year after diagnosis of breast ( ADDIN EN.CITE [], see explanation above). It predicted a ‘mild’ trajectory. 
When it was the only personality variable entered in regression models, trait anxiety predicted emotional dysfunction two to five years after surgery for rectal cancer  ADDIN EN.CITE [], and depression two years after diagnosis of breast cancer [].  However, it did not predict depression 12 months after diagnosis if other personality measures were controlled for (neuroticism, agreeableness) [].
3.3.4. Perceived control	
Despite the salience of perceived control in psycho-oncology, only six papers (five studies) examined this variable, with just three finding positive effects.  In breast cancer, pre-operative ‘personal control’ did not predict emotional distress 12 months later [], although greater post-operative perceived control (a latent variable inferred from scores on ‘fighting spirit’ and ‘self–efficacy’) did predict improvement in emotional distress over the subsequent year  ADDIN EN.CITE [].  In a sample of breast and prostate cancer patients, pre-treatment personal control predicted anxiety 12 months later but not depression or trauma symptoms  ADDIN EN.CITE [].  In another study with mixed cancer diagnoses  ADDIN EN.CITE [], ‘sense of coherence’ (a similar construct to perceived control) at diagnosis predicted lower anxiety and depression 14 months later.  In head and neck cancer patients  ADDIN EN.CITE [, ] cancer locus of control (a sense of personal control over the cause and course of cancer) had no relationship with depression one to three years after treatment.  
3.3.5 Illness / treatment perceptions
Three of five papers (five studies) that explored whether patients’ appraisal of their illness predicted longer-term distress used a standardised measure of illness perceptions while the remaining two used single-item measures.  Only two found any effects.  In one [], of four illness perception factors assessed only post-operative ‘illness identity’ (perceived symptom burden) predicted emotional distress 12 months later among breast cancer patients.  In the second, after controlling for baseline distress,  just one of eight illness perception factors (‘personal control’) predicted anxiety, but not depression or trauma symptoms, after treatment for breast or prostate cancer  ADDIN EN.CITE []. 
3.3.6 Metacognitive beliefs
One paper  ADDIN EN.CITE [] examined whether metacognitive beliefs (i.e. positive and negative beliefs about cognition) predicted distress 12 months after treatment for breast or prostate cancer.  After controlling for pre-treatment distress and illness perceptions, one of five metacognitive subscales (‘cognitive confidence’) predicted anxiety and depression, but not trauma symptoms.
In summary, of the psychological factors examined, only baseline distress and neuroticism consistently predicted longer-term emotional distress.  

4.	Discussion
This study is the first comprehensive  review of prospective predictors of longer-term distress after cancer.  The specific aim was to identify variables measured before, or within three months of, cancer diagnosis that predicted  distress at least 12 months later.  A systematic search of literature identified 39 papers reporting 36 studies that examined a wide range of clinical, demographic, social and psychological variables.  Only two variables consistently predicted longer-term distress after cancer: baseline level of distress, supported in 26 out of 30 papers (24 out of 28 studies) that examined this variable, and neuroticism (supported in five out of five papers/studies). All the other putative predictor variables have either been examined in fewer than four papers/studies, and/or were significant in ≤50% of the papers that tested them.  
Although socio-demographic risk factors for distress after cancer are often suggested to be similar to those in the general population [], the predominance of negative findings in this review suggests they are not important predictors, at least when other variables are included in analyses.  Similarly, despite the popular belief that clinical factors (i.e.  treatment type, tumour characteristics) are likely to influence levels of distress,  we found no clear evidence to support this view in the longer-term.  The only clinical variable for which there was modest evidence was pre-morbid physical health.  However, even in this case the findings were inconsistent, with as many papers finding no effect (i.e. six out of twelve papers /five out of ten studies) as those reporting significant prediction.  This lack of association between clinical factors and distress is consistent with ideas from health psychology and psycho-oncology research that emotional distress is more closely linked to individuals’ appraisal of their clinical condition and context rather than to the clinical factors per se  ADDIN EN.CITE [, ].  However, this review also found no consistent evidence that measures of illness appraisal predicted longer-term distress.
Despite the long-standing view that social factors, in particular social support, protect against distress  ADDIN EN.CITE [, , ], we found no evidence that social support variables reliably predicted longer-term distress.  It may be that null findings reflect the difficulty of disentangling the effects of social support from other factors around the time of diagnosis, particularly baseline distress which was controlled in most studies and with which social support is likely to be highly correlated.  Alternatively, the inconsistent results reported across studies in relation to perceived social support may be due in part to the different ways that this variable was operationalised.  The fact that one paper (Ranchor et al, 2002)  reported a direction of effect contrary to expectation (more baseline social interaction predicted greater emotional distress 12 months later) suggests a need to revisit the construct  of ‘social support’ in future research and recognise it as complex and multi-dimensional.
Of the psychological variables studied,  just baseline distress and neuroticism consistently predicted longer-term distress.  Studies of optimisim/pessimism, perceived control and self-esteem provided no clear evidence for the reliability of these variables as predictors.  Reports of significant prediction by measures of coping, illness perceptions and metacognition should be interpreted with caution because significant findings arose for isolated subscales from larger questionnaires and might therefore be Type 1 errors.  In addition, the considerable variability in how coping and illness perceptions, in particular, were measured further compounds the difficulty of discerning any pattern in the findings reported across studies. 

4.1 Strengths and limitations
This study is the first to use a rigorous and systematic approach to review research on prospective predictors of longer-term distress after diagnosis and treatment of cancer.  Narrative synthesis allowed us to include studies predicting a broad range of indicators of distress.  However, the heterogeneity of included studies, particularly in the populations studied, the methods used to measure predictor and response variables, and procedures of data analysis, limits the conclusions that can be drawn.
Despite a comprehensive database search strategy it is possible that some relevant research was missed.  However, the main findings of the review are likely to be robust to missing studies; that is, given the general variability in methods and findings in this field, robust conclusions have to be drawn from findings across several studies rather than be based on isolated studies.  Indeed, some variables (i.e. self esteem, metacognitive beliefs) have been examined in only one paper; these variables therefore need further research to test and expand the preliminary findings that have been reported before any conclusions can be reached. 

4.2 Clinical and research implications
This review has several important clinical and research implications.  The most compelling finding that distress within 3 months of diagnosis predicts longer-term distress (at least when the same measure is used) shows that, for many patients, distress is a persistent problem.  This finding supports current guidance for assessing distress around diagnosis as a marker of those vulnerable to longer-term distress [] [].  However,  it cannot be assumed that it is always necessary or even appropriate to treat distress detected so soon after diagnosis [].  Indeed, recent reports have suggested that patients do not necessarily want such early intervention [], and post-traumatic stress disorder literature has suggested that early intervention can do more harm than good  ADDIN EN.CITE [, ].  Furthermore, although baseline distress may be a useful marker of future vulnerability it remains unknown how or why distress is maintained for some patients and not others.  In standard multivariate regression analyses of the kind used in the literature reviewed here, baseline distress inevitably dominates in predicting future distress and so might mask the predictive effect of other measured baseline variables that could be important in causing distress to persist  ADDIN EN.CITE [].  In the present review, one study used advanced statistical methodology to separate the enduring component of distress from the change in distress over time.  Using latent growth curve analyses, this study reported three significant predictors of change in distress: baseline distress (intercept); baseline perceived control; and change in perceived control (slope). It found that the rate of change in perceived control (i.e. slope) was the strongest predictor  ADDIN EN.CITE [].  Use of such advanced statistical approaches will provide greater opportunity for identifying the putative causal variables that underlie persistent distress.
Neuroticism emerged from the review as the second consistent indicator of vulnerability.  Furthermore, the specific finding by Aarstad et al  ADDIN EN.CITE [] that neuroticism reduced to non-significant the effect of depression at diagnosis on depression at 6 years implies that enduring characteristics of the individual, rather than the more transient emotional responses, appraisals or coping strategies that arise around the time of diagnosis, explain why distress persists.  However, until the psychological mechanisms underlying the association between neuroticism and persistent distress are clearer, this finding is of limited help in guiding intervention.  
This review highlights important gaps in the literature. In particular, several of the predictor variables examined (i.e. social class, income, social network, negative life events, self-esteem, Type C personality, trait anxiety and metacognitive beliefs) were tested in fewer than four papers. Consequently, there is insufficient evidence to determine whether these are relevant predictors; these understudied variables should be tested in future research.
From our review it is clear that, to understand longer-term distress after cancer diagnosis, research is required that both acknowledges and controls for the persistence of distress while also seeking to identify the variables that have a causal role in maintaining  distress.  Such research requires a strong theory-driven approach.  This review suggests there is currently only limited evidence to support the role of factors such as appraisal and coping, which are  key components of traditional cognitive models of adjustment in cancer.  Emerging models in mental health, such as relational frame theory [] or the metacognitive model [, ], provide an alternative direction for research.  This review found only one study that drew on such approaches, reporting that metacognitive beliefs predicted longer-term distress  ADDIN EN.CITE [].  As an isolated finding it is premature to draw conclusions from it in the context of this review. Nevertheless, further exploration of metacognitive and other theoretically derived potential causal variables is now needed.  

5.	Conclusion
This review found that distress and neuroticism, measured around the time of cancer diagnosis, are the only consistent indicators of vulnerability to long term emotional distress that have, until now, been identified.  However, to understand  the causes of this vulnerability and to develop interventions to reduce vulnerability, research needs to identify the psychological factors that maintain distress, and not just those that predict it.  To achieve this, future  research, based on testable theory, will need to adopt more sophisicated longitudinal designs and statistical methodology so that it can disentangle the persistence of distress from its causation.
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Table 1: EBSCO database search strategy
Connector	Search Term	Search field
	cancer	All fields
AND
	emotional distress OR psychological distress OR anxiety OR depress* OR posttraumatic stress OR  PTSD OR psychological morbidity OR psych*, adjustment OR emotional adjustment OR mood OR adjustment disorder OR acute stress disorder OR fear of recurrence OR distress	All fields
AND
	predict* OR risk factorsOR caus* OR vulnerability	All fields
NOT
	adolescent cancer OR child* cancer OR paed*carers OR palliative	Abstract
NOT		
	genetic testing OR genetic screening	Abstract
NOT		
	palliative OR metastatic cancer ORadvanced cancer OR survival OR mortality	Title



 Table 2 Sample characteristics of 39 included papers (36 studies)
Paper	Diagnosis	% Female	T1 Sample N	T2 Sample N	Attrition (%)	Age Mean (SD) 	Age Median (range)	Country
Dean 1987[]	BC	100	122	111	9	48.7	(20-60)	UK
Ramirez et al, 1995[]	BC	100	102	91	11	-	56 (24-69	UK
Carver et al, 1998 ADDIN EN.CITE []	BC	100	66	61	8	52.9 (11.2)	(28-76)	USA
Tjemsland et al, 1998[]	BC	100	106	91	14	-	50 (33-70)	Eur
Hammerlid et al, 1999 ADDIN EN.CITE []	HN	28	357	215	40	63 	(18-88)	Eur
Bleiker et al, 2000[]	BC	100	244	200	18	51.9 (10.5)	(29-75)	Eur
de Leeuw ,et al 2000 ADDIN EN.CITE []*	HN	21	204	155	24	59 (10.8)	-	Eur
de Graeff, et al 2000 ADDIN EN.CITE []*	HN	20	204	153	25		(29-76)	Eur
De Leeuw 2001[]*	HN	22	204	171/139/123	16-40	59 (10.6)	-	Eur
Ranchor et al, 2002[]	Mix	42	167	99	41	73.4 (7.46)	-	Eur
Stanton et al 2002[]	BC	100	80	70	12.5	52.6 (11.94) 	30-80	USA
Mehta et al, 2003 ADDIN EN.CITE []	PC	0	519	259	50	64.8 (4.8)	-	USA
Shroevers, Ranchor & Sanderman, 2003** ADDIN EN.CITE []	Mix	73	475	403	15	58(14.3)	-	Eur
Shroevers, Ranchor & Sanderman, 2003**[]	Mix	73	475	403	15	58(14.3)	-	Eur
Uchitomi et al, 2003 ADDIN EN.CITE []	LC	40	262	212	19	62.1 (10.8)	63.5 (22-83)	Japan
Schou et al 2004 ADDIN EN.CITE []	BC	100	195	165	15	56 (10.3) 	21-78	Eur
Aarstad et al, 2005 ADDIN EN.CITE []	HN	0	27	27	0	59.9 (1.3)	-	Eur
Millar et al 2005[]	BC	100	371	279	25	59.4 (10.9) 	29-98	Eur
Steginga et al, 2006 ADDIN EN.CITE []	PC	0	111	104	6	61.54 (8.13)	-	Eur
Gustavsson-Lilius et al, 2007 ADDIN EN.CITE []	Mix	68	349	123	65	58 (8.6) 	34-76	Eur
Lebel et al, 2008 ADDIN EN.CITE []	BC	100	146	86	41	61-7 (10.8) 	37-88	Can
Barez et al, 2009 ADDIN EN.CITE []	BC	100	129	101	22	48.03 (8.4)	25-65	Eur
Den Oudsten et al, 2009[]	BC	100	223	144	35	58.7 (9.4)	-	Eur
Ristvedt & Trinkaus, 2009 ADDIN EN.CITE []	RC	44	123	80	35	67.5 (12)	29-88	USA
Couper et al, 2010[]	PC	0	211	175	17	66.2 (8.3)	43-92	Aus
Scharloo et al, 2010 ADDIN EN.CITE []	HN	24	177	95	46	59.6 (10.8)	36-84	Eur
Elklit & Blum, 2011[]	BC	100	81	64	25	56.3(9.1)	41-89	Eur
Lee et al, 2011 ADDIN EN.CITE []	BC	100	299	206	31	-	20-79	Korea
O’Connor et al, 2011[]	BC	100	3318	2912	7	-	55.7 (26-70)	Eur
Carlson et al 2013 []	Mix	43	877	505	42.5	62.3(14.1)	-	Can
Lockefeer & de Vries, 2013[]	BC	100	227	163	28	58.9 (9.3)	-	Eur
Neilson et al, 2013  ADDIN EN.CITE []	HN	16	101	37	63	63 	37-85	Aus
Adachi et al, 2014 ADDIN EN.CITE []	HN	22	116	78	33	61.2(11.4) 	20-85	Japan
Hou & Lam, 2014[]	RC	38	234	180	33	64.4(10.6)	67 (29-82)	HK
Kohler et al, 2014[]	PC	0	390	329	16	65.3 (6.4)	-	Eur
Cook et al, 2015[]	BC/PC	65	229	206	10	61,6 (9.0)	39-58	UK
Stafford et al, 2015 ADDIN EN.CITE []	BC/GC	100	264	105	60	53.1 (13.0)		Aus
Pérez et al, 2016 ADDIN EN.CITE []	BC	100	126	102	19	50.5 (8.7)	27-68	Eur
Saboonchi et al, 2016[]	BC	100	750	750	0	51.3 (8.1)	52 (24-63)	Eur
N.B: BC – breast cancer; Mix – heterogeneous cancer diagnoses; HN – Head & Neck Cancer; PC– prostate cancer; LC – lung cancer; RC – rectal cancer; GC – Gynaecological cancer; UK – United Kingdom; Eur  - Europe; USA – United States of America; Aus – Australia; Can – Canada; HK-Hong Kong’*three papers report one study; **two papers report one study; 

Table 3 Summary of study design and significant findings from included papers (grouped by outcome (DV))
Article	Cancer Diagnosis	T1	T2 (N months later)	Dependant Variable (DV)	 T1 DV controlled	Analysis	Medical /demographic	Social /Environmental	Psychological	Significant Findings (p<.05)
DV - ANXIETY/DEPRESSION CASE
Dean 1987	Br	Pre-op	12	Anx or Dep case (PSE)	Y	Stepwise LR	Menopausal status, Trt,  Social class,	Marstat, Confidant	Pre-op case (RDC/GHQ)Coping stylePsy TrtAttitude 	Lower social class OR 4.57Pre-op case OR 4.37Perimenopausal OR 8.9Marital status (married) OR 5.85(results not clear)
Ramirez et al 1995	Br	Pre-op	12	Anx or Dep case  (PSE)	N 	ROC			ED (HADS>10)	HADS  >10 identified in 83% cases 
Hammerlid et al 1999	HN	Diag	12	Anx or Dep case (HADS) 	Y	LR	KPS, Age, Gender, TSite, TStage	Living status	Baseline Anx or Dep case	Anx or Dep case at diagnosis - no data provided
Shroevers et al, 2003*	Mix	Post-Trt (3 month post-diag)	15	Change in Dep case status over time (CES-D)	N	Repeated measures Anova	TSite, TStage, Trt, Age, Gender, Educ	Marstat		Greater reduction in Dep with lower stage disease (stage 1 vs stage 2 or higher) F [2,332], p<.05 and higher education F [3,332], p<.01
Schou et al 2004	Br	Diag	12	Dep case  (HADS)Anx case (HADS)	YY	LR	Educ, Tgrade,Trt 	Previous cancer/serious illness experience	Optimism /pessimism, +VE Trt expectation,Anxi/Dep, Coping	Dep Case: low Opt OR = 0.83; Anxious preoccupation OR = 3.2Anx Case: low Opt OR = 0.86; Anx OR = 2.71; fatalism OR = 3.16
Uchitomi et al 2003	Lc	Post-Trt(1 mth)	12	MD Case(SCID))	Y	LR (backward)	Age , Gender, Educ, Pre-op  smoking, Pre-op TStage, Trt, dypsnea, Forced expiratory volume (FEV)	Marstat,	Pre-morbid/ pre & post Trt MD, post Trt ED	Post-Trt MDD OR = 2.1, Educ OR =  2.4
DV - ANXIETY/DEPRESSION
De Leeuw et al 2000**	HN	Pre-Trt	12	Dep (CES-D)	Y	Hierarchical MR (stepwise)	TStage  Trt, Age, Gender, Symptoms, General health, Physical functioning	Received/available support, perceived social network	Coping, Locus of Control, Dep	TStage R2c =.0 4Dep  R2c =.20Available supp R2c = .07Social network R2c = .04Gen Health R2c =.02
De Graeff et al 2000**	HN	Pre-Trt	12	Dep (CES-D)	NY	MR (stepwise)	Gender, Age , Group(site, stage, Trt),  Karnovsky Performance Status  (KPS), symptoms 		Dep	Dep R2c = .21KPS R2c  = .03Grp R2c =.02
De Leuw et al 2001**	HN	Pre-Trt	12, 24,36	Dep (CES-D)	Y	MR (stepwise)	Physical function , Symptoms, Trt, Recur, Tstage, Age, Gender	Received/available support, perceived social network openness to discussion	Dep, Coping, Locus of  Control	Largest predictor Dep R2c =.18 @ 1yr.31 @2yr.31 @ 3 yrsCoping R2c =.02 @ yr1 (Religious), .02 @ yr3 (Palliative coping) Emotional support variables R2c  = .14 @1 yr, .06 @ 2 yrs, .03 @ 3 yrs (incl. Social network & support)Physical/dem og R2c = .01 @yr1, .02 @ yr 2, .10 @ yr 3
Shroevers 2003*	Mix	Post-Trt (3 month post-diag)	15	Dep (CES-D)	Y	MR (Stepwise)	Sociodemog (not stated) ,Group membership (patient vs. control)	Social support	Dep, Self-esteem	Dep  β  = 0.59Problem focussed support   β  = 0.11Negative interactions  β  = 0.09Negative self-esteem (not shown )
Aarstad et al 2005	HN	Diag	72+	Dep (BDI)	Y	Partial Correlation			Anx; Dep ; Humour; 	Dep r =0.39 Not sig after controlling for T1 neuroticism; Humour r = 0.42r=0.64  after controlling for T1 neuroticism
Gustavsson et al 2007	Mix	Diag	14	Anx (EMAS-State)Dep (BDI)	Y	SEM - path analysis	Gender, Educ, TStage	Partner sense of coherence (SOC)	SOC (life as predictable/manageable/meaningful) Anxiety, Dep	Anx DV:  Anx  β  =0.32, in direct effect of T1 SOC via T2 SOC  β  =-0.30, via T1 Anx  β  =-0.15Dep DV: Dep  β  =0.36, in direct effect of T1 SOC via T2 SOC  β  =-0.30; via T1 Anx  β  =-0.22
Den Oudsten et al 2009	BC	Pre-diag	12	Dep (CES-D)	Y	MR (stepwise)	Age, Empstat, Educ, Surgery, Adj Trt, Tstage, Tsize, Fatigue, Pain & discomfort	Social support,living with partner, living with children	Personality, Dep, trait Anx, Self-esteem, Body image, Cognitive function	Fatigue  β  =0.28, Neuroticism  β  =0.16, Surgery  β  =-17, Agreeableness  β  =-0.15 Dep 0.22
Couper et al 2010	PC	Pre-Trt	12	Dep Anx (BSI)	YY	Hierarchical MR	HRQoL		Dep, Anx,, Coping 	Dep DV:  Dep  β  = 0.48, QoL-vitality  β  = 0.24, Fatalism  β  = 0.13Anx DV: anx  β  = 0.62, QoL-vitality  β  = -0.19
Lee et al 2011	BC	Diag 	0-12 month 	Deteriorated Dep  (Zung-SDS)	N	Hierarchical LR  (Cross-sectional)	Age, Co morbidity, smoking, Menopausal status, Deteriorated finances, Radiotherapy, Deteriorated role functioning	T1 predictors -Deteriorated emotional support 		No T1 Sig predictors. Deteriorated emotional support OR = 3.4, Deteriorated finances OR = 2.9, Deteriorated role functioning  = 2.3
Carlson et al 2013	Mix	1 month since diag	12	Improved Dep (PSSCAN)Improved Anx(PSSCAN)	Y Y	MR (improved DV)	Age, Gender, Source of income , Educ, Ethnic/cultural background TSite , Trt	psychosocial resources,  marstat,  livstat,	Anx, Dep	Dep DV: Dep  β  =-0.48, No radio  β  =0.08, psychosocial resources  β  =0.10,Anx DV:  Anx  β  =-0.42Anx x married  β  =-0.11Anx x no radio  β  =0.11Anx x not gastro cancer  β  =-0.11
Lockefeer & Defries 2013	BC	Pre-diag	24 	Dep (CES-D)	Y	Hierarchical MR 	Age Educ, empstat,  TSite, Chemo, Radio, HT, Fatigue, Sleep quality	partner, , children,	Dep, trait Anx	Trait anxiety  β  = 0.37, Fatigue  β  = 0.23
Neilson et al 2013	HN	Pre –Trt	18 post Trt 	DepAnx
(HADS)	NN	Multi-level mixed effects linear regression	Time, Age, Gender, Chemo, Pain, Symptoms, Trt	livstat,		Dep DV: Symptoms  β  = -.24Anx DV: Age  β  = 0.54, symptoms  β  = -0.09e
Adachi et al 2014	HN	Pre-op	12	Dep (HADS) 	Y	MR (stepwise)	Gender, Facial disfigurement	Social support	Dep, Coping, Trauma 	Dep   β  =-0.59
Cook et al, 2015	BR/PR	Pre-trt	12	DepAnx(HADS)	Y	Hierarchical MR	Age, Gender	-	AnxDepIllness perceptions (inc. Personal control)Metacognitive beliefs	Anx DV:  Age  β  = 0.18; anxiety β =0.46; Personal Control β = -0.11; Cognitive confidence β=0.13Dep DV:  Age  β  = 0.14; depression β =0.41; Cognitive confidence β=0.20
Stafford et al, 2015	BC/GC	Pre-op	12, 18, 24	Dep (CES-D)Anx (HADS)	N	Hierarchical MR	Age,  Educ,  TSite; Chemo, Radio	Living alone,  	Psychiatric trt at diag (PTd)Psychaitric treatment prior to diagnosis (PTh)Neuroticism	Anx DV: neuroticism β  = 0.31; PTd β  = 0.24  @12 months ;  PTd β  = 0.31  @18 months ;neuroticism β  = 0.27; @24 months ;Dep DV: neuroticism β  = 0.21; PTh β  = 0.32  @12 months ;  neuroticism β  = 0.31; PTd β  = 0.26  @18 months ;neuroticism β  = 0.33; @24 months ;
Saboonchi et al, 2016	BC	Post-op	12,24	DepAnx (HADS)	N	LGC	Age, Educ, Adj trt	Marstat	Personality (optimism, Pessimism)	Dep DV (R2= .51):   optimism intercept b  = -1.01;Anx DV (R2= .39):   :  optimism intercept  b   = -0.82, Educat  b   = .90
DV – TRAUMA SYMPTOMS
Tjemsland et al 1998	BC	Pre-op	12-16	Trauma (IES)	Y 	MR	Age, Adj  Trt, Health problem / Medications in last 10yrs, Recurrence	Work/social/family function, Lack of crisis support, Life events	Emotionality (EPI-N), Intrusion, PTSD casesness	Emotionality  β  = 0.45Intrusion  β   =0.36Medication  β  =  0.34Adj Trt  β  = -0.17Age  β  = -0.16 
Bleiker et al 2000	BC	Post-op 	18 (21 after surgery)	Intrusion Avoidance(IES)	Y	MR (Backward)	Age, Surgery, Lymph nodes, Adj Trt, Sleep, Health complaints (SCL-90)	Life events, Perceived social supp (SEC)	Intrusion, Avoidance, Anx, Anger Dep, Personality (Optimism, Rationality, Anti-emotionality, emotional expression )	Intrusion DV:  T1 Intrusion  β  = 0.60Health complaints  β = 0.28Sleep problems  β  = 0.25Avoidance DV, T1 avoidance explained 47%no beta provided
Lebel et al, 2008**	BC	Post-Trt	72	Trauma (IES)	Y	Hierarchical  MR (stepwise)	Age,  Educ, 2nd cancer, Perceived health	Social support	Coping, Optimism, Fear of future, Stress appraisal , Emotional distress, Trauma	Trauma  β  =-0.52, 2nd cancer  β  =-0.19
Risvedt & Trinkaus 2009	RC	Post-op	24-60	Trauma (IES)	N	LR	Gender, Age, Educ,TStage, Ostomy , Faecal incontinence		Trait anxiety	Faecal Incontinence  OR 1.05
Elkit & Blum 2011	BC	Post op 	13 post diag	Trauma  (HTQ)	N)	Hierarchical MR			Immature defence style, Emotional coping, Avoidance. Negative affectivity	Avoidance  β  =0.25, Negative affectivity  β  = 0.55
O’Connor et al, 2011	BC	Pre-morbid	15 post-op	Trauma(IES ≥35)	Y 	LR	Step1: Age, Educat, Income, Net wealth, Ethnicity, Co-morbidityStep 2: Nodal Involvement, Tstage, Tsize, Receptor status, Surgery, Chemo, Radio, Hormone Trt	Step 1: Marstat, Children, Urban	Step 1: Psychiatric History	Step 1: Income OR (95% CI) 0.64 (0.43-0.95), Net Wealth OR (95% CI) 0.50 ().33-0.75), Psychiatric History OR (95% CI) 1.78 (1.16-2.72)Step 2: Nodal Status OR (95% ci) 1.81 (1.37-2.40)
Cook et al, 2015	BC/PC	Pre-Trt	12	Trauma(IES)	Y	Hierarchical MR	Age, Gender		traumaIllness perceptions (inc. personal control)Metacognitive beliefs	Trauma. β =0.44; 
Pérez et al, 2016	BC	Pre-op	12	Trauma (Symptom trajectory groups: Chronic, Mild, Delayed-recovered, Resilient)(SASRQ)	Y	MLR
(ref: Resilient)			Type C Personality, Coping 	Mild: Anxious preoccupation β =0.30  OR (95% CI) 1.09-1.65;  Cognitive Avoidance β =0.21 OR (95% CI) 1.01-1.51,  Type C β =0.38 OR (95% CI) 1.07-1.98;Chronic: Anxious preoccupation β =0.78, OR (95% CI) 1.27-3.89;  
DV - EMOTIONAL DISTRESS/FUNCTIONING
Carver et al 1998	BC	Pre-Trt	12	ED (Affects Balance Scale)	N	MR 	Age		Body image , Appearance concern, Body integrity concern	None sig
De Graeff et al 2000**	HN	Pre-Trt	12	EF (QLQ-C30-EF)	NY	MR (stepwise)	Gender, Age , Group(Tsite, Tstage, Trt),  Karnovsky Performance Status  (KPS), symptoms 		Dep	Dep R2c= 17KPS R2c=.0 4Gender R2c  = .02Grp R2c  = .01
										
Ranchor et al 2002	Mix	Pre-morbid	12	ED (GHQ-12)	Y	Hierarchical MR	Age, Gender, Educ	Social support	ED, Neuroticism , Self-Efficacy	ED   β  = 0.26, Neuroticism  β  = 0.22, Social support  β  = 0.38
Stanton et al, 2002	BC	Pre-op	12	ED (POMS)FOR (Fear of Recurrence Scale)	YY	Hierarchical MR	Age		Distress, Vigor, Coping, Hope, 	ED DV: ED & age R2c = .30, Coping R2c = .14, Hope x coping R2c .21FOR DV – FOR R2c = .46, Hope x coping R2c  = .19
Uchitomi et al 2003	LC	Post-Trt(1 mth)	12	ED (POMS)	Y	MR (backward)	Age , Gender, Educ, Pre-op  smoking, Pre-op TStage, Trt, dypsnea, Forced expiratory volume (FEV)	Marstat,	Pre-morbid/ pre & post Trt MD, post Trt ED	Post-Trt distress  β  = 0.47, Pre-Trt MDD  β  = 0.18
										
Millar et al 2005	BC	Post-op	12	ED (GHQ-28)	Y	MR (Stepwise)	Age, Deprivation, General health, Physical function, Pain		Illness perceptions (inc. personal control), Coping, Personality, Distress	Distress  β  =0.32; IPQ Identity  β  = 0.44; Neuroticism  β  =0.34
Steginga & Occhipinti 2006 	PC	Pre-Trt	12	Decisional distress (Decisional conflict scale)	Y	Hierarchical MR			Optimism, Cancer threat, Coping, Decisional distress	Decisional distress  β  =.515
Lebel et al, 2008**	BC	Post-Trt	72	ED (POMS)	Y	Hierarchical  MR (stepwise)	Age,  Educ, 2nd cancer, Perceived health	Social support	Coping, Optimism, Fear of future, Stress appraisal , Emotional distress, Trauma	Coping (PPS)  β  =-0.28
Barez et al 2009	BC	Post-op	12	ED (HADS & POMS combined)	Y	LGC	Age , Trt, 		Baseline Perceived control  (PC) Change in PC	Change in perceived control  β  =-0.81; Intercept perceived control   β  =-0.31; Intercept distress  β  =-0.51; Intercept perceived control via change perceived control  β  =-0.28
Risvedt & Trinkaus 2009	RC	Post-op	24-60	EF (FACT)	N	LR	Gender, Age, Educ,TStage, Ostomy , Faecal incontinence		Trait anxiety	EF : Trait anxiety OR 1.45, 
Scharloo et al 2010	HN	Diag	24	EF (QLQ-C30 - EF)	Y	Hierarchical MR (Forced / stepwise)	Age, Tstage		Illness perceptions , EF	EF  β  =-0.65
Carlson et al 2013***	Mix	1 month since diag	12	Improved Emotional distress (Distress Thermometer)	Y 	MR 	Age, Gender, Source of income , Educ, Ethnic/cultural background TSite , Trt	psychosocial resources,  marstat,  livstat,	Anx, Dep	Distress DV:  Distress   β  =-0.56, No surgery  β  =0.08, 
Hou & Lam, 2014	RC	<12 weeks since diagnosis 	12	ED(HADS)	Y	Cross-Lagged Panel Model			EDWell-being (WB:positive affect + life satisfaction)	EDT1- EDT2 b=.26 & EDT2-EDT3 b=.27;WBT1-EDT2 b-.16 & EDT2-EDT3 b=.27;WBT1-WBT2 b=.34 & WBT2 – EDT3 b=-.16
										
Kohler et al, 2014	PC	Pre-Trt	12 post surgery	ED (HADS)	Y	MR	Concurrent urinary symptoms and erectile dysfunction		ED	ED  = 0.48, Concurrent urinary symptomd  β  = 0.39
Mehta et al 2003	PC	Pre-Trt	NOT clear if prospective or cross-sectional	Fear of Cancer Recurrence (FCR)	N	MR	Age, Clinical characteristics, Trt, HRQoL,(SF-36) Symptoms			QoL-physical R2c = 0.27, QoL-mental R2c = 0.04 (no data)
N.B: BC – Breast cancer, LC – Lung cancer, HN – Head & Neck cancer, PC – Prostate cancer, GC – Gynaecelogical cancer, RC – Rectal Cancer, Mix - heterogeneous cancer diagnoses; Diag – diagnosis; Op – Operation/surgery; Trt – Treatment; MD – Major Depressive Disorder; GAD – Generalised Anxiety Disorder; Anx – Anxiety; Dep  - Depression; Trauma – Trauma symptoms; EF – Emotional Functioning; ED – Emotional distress; Opt – Optimism; ROC – Receiver Operating Curve; MR – Multiple regression, (M)LR-  (Multinomial)Logistic regression; R2c - R2Change; β = Beta; OR = Odds ratio; HR = Hazards Ratio; R = Correlation; Only coefficients sig p<.05 are shown; HRQoL – Health related Quality of Life; TStage – Tumour stage; Tsize – Tumour size; TSite – Tumour site/clinical characteristics; Recur – cancer recurrence; Adj Trtr – adjuvant treatment; Chemo – Chemotherapy, Radio – radiotherapy, HT  - Hormone Therapy; Educ – Education; Marstat – Marital status, Livstat – Living alone/with others; Empstat – Employment status; Grey font  - cross-sectional




Table 4: Glossary of distress measures (DVs) used in included papers
Measure	Abbreviation	Outcome assessed
Present State Examination	PSE	Anxiety/ Depression Cases
Structured Clinical Interview	SCID	Major Depressive Disorder/ Generalized Anxiety Disorder
The Psychological Screen for Cancer 	PSSCAN	Anxiety / Depression Cases
Hospital Anxiety and Depression Scale 	HADS	Anxiety / Depression / Emotional Distress
The Center for Epidemiologic Studies  Depression Scale	CES-D	Depression
Beck Depression Inventory	BDI	Depression
Hamilton Depression Rating Scale	HDRS	Depression
The Zung Self-Rating Depression Scale	Zung - SDS	Depression
Brief Symtom Inventory	BSI 	Anxiety / Depression
Endler Multidimensional Anxiety Scales	EMAS-State	Anxiety
Post-traumatic Stress Disorder Checklist – Civilian version	PCL-C	Trauma Symptoms
Impact of Events Scale	IES	Trauma Symptoms
Harvard Trauma Questionnaire	HTQ	Trauma Symptoms
Stanford Acute Stress Reactions Questionnaire	SARSQ	Trauma Symptoms
Profile of Mood State	POMS	Emotional Distress
General Health Questionnaire	GHQ- 28 / GHQ 12	Emotional Distress
Distress Thermometer	DT	Emotional Distress
The European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire – Emotional Functioning Scale	QLQ-C30 – EF	Emotional Functioning
Functional Assessment of Cancer Therapy-General – Emotional Functioning Scale	FACT-G - EF	Emotional Functioning
Affects Balance Scale 	ABS	Emotional Distress
Decisional Conflict Scale	DCS	Decisional Distress
Fear of Recurrence Scale	FCR	Fear of Cancer Recurrence
Fear of Recurrence Scale	FOR	Fear of Cancer Recurrence
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